Problematic aspects of sentinel lymph node biopsy and its relation to previous excisional biopsy in breast cancer

Clinical Nuclear Medicine

Volumn 34, Issue 12, 2009, Pages 854-858

  Yararbas, Ulkem ^a   Argon, A Murat ^a   Yeniay, Levent ^a   Kapkac, Murat ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Excisional biopsy; Sentinel lymph node biopsy; Tc 99m tin colloid

Indexed keywords

TECHNETIUM TIN COLLOID TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST AREOLA; BREAST BIOPSY; BREAST CANCER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ACTIVITY; FEMALE; HUMAN; INCISION; LYMPH VESSEL; MAJOR CLINICAL STUDY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 74249092806     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181becec2     Document Type: Article

References (24)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer. 1989;63:181-187.
2. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83:2776-2781.
3. Schulze T, Mucke J, Markwardt J, et al. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol. 2006;93:109-119.
4. Stubblefield MD, Custodio CM. Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil. 2006;87:S96-S99.
5. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-466.
6. Morton DL, Wen DR, Wong Jh, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
7. Alazraki NP, Eshima D, Eshima LA, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med. 1997;27:55-67.
8. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-340.
9. Giuliano AE, Kirgan DM, Guenter JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
10. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864-1867.
11. Wong SL, Edwards MJ, Chao C. The effect of prior biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272-277.
12. Haigh PI, Hansen NM, Qi K, et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol. 2000;7:21-27.
13. Luini A, Galimberti V, Gatti G. The sentinel node biopsy after previous breast surgery: Preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat. 2005;89:159-163.
14. Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg. 1999;188:248-254.
15. Ohtake E, Asaga T, Inaba M. Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy. Ann Nucl Med. 2005;19:671-675.
16. Kim S, Krynyckyi BR, Fedorciw BJ, et al. Extremely indirect dermal lymphatic channels: value of areolar-cutaneous junction injection technique for breast lymphoscintigraphy. Curr Surg. 2005;62:335-337.
17. Heuts EM, van der Ent FW, Kengen RA, et al. Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol. 2006;32:278-281.
18. Chagpar AB, Scoggins CR, Sahoo S, et al. Biopsy type does not influence sentinel lymph node status. Am J Surg. 2005;190:551-556.
19. Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002;131:277-286.
20. Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg. 2000;231:614-615.
21. Mudun A, Sanli Y, Ozmen V, et al. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Clin Nucl Med. 2008;33:262-267.
22. Argon AM, Duygun U, Acar E, et al. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node. Clin Nucl Med. 2006;31:795-800.
23. Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localization and false-negative rates of sentinel lymph node biopsy in breast cancer- results of ALMANAC validation phase. Breast Cancer Res Treat. 2006;99: 203-208.
24. Hughes M, Goffman TG, Perry RR, et al. Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer. Am J Surg. 2004;187: 52-57. (Pubitemid 38054355)